{"disease":{"id":"female-genital-fistula","name":"female genital fistula"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05437939","title":"Adverse Outcomes Following Female Genital Fistula Repair","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":802,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04748653","title":"Fistula Reintegration Pilot","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"University of California, San Francisco","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}